close icon

Amgen Stock in Trouble, Despite Strong Results

Amgen Inc. (NASDAQ:AMGN) reported its full year 2017 results on February 1st. On a non-GAAP basis, the California-based biotech giant earned $12.58 per share, an 8% increase from 2016. But instead of celebrating another year of strong business performance, investors punished Amgen stock, which fell from an all-time high of $201.22 to $168.45 between January 29th and February 9th.

The selloff was probably driven by the company’s earnings miss in the fourth quarter. Or maybe it was the poor guidance for 2018. In our opinion, investors only used these as an excuse to get rid of the stock. The real reason for the decline, we believe, was the market itself, which was already anticipating bad news by the time Amgen’s report became public. Trouble is, the Elliott Wave Principle suggests this was just the beginning of an even bigger pullback.
amgen stock weekly elliott wave analysis
The weekly price chart of Amgen stock shows that the uptrend from $39.16 to $201.22, which has been under construction for almost 10 years since March 2008, took the shape of a five-wave impulse, labeled (1)-(2)-(3)-(4)-(5). Wave (3) is extended, but the five sub-waves of the ending diagonal pattern in wave (5) are also visible.

The bad news for Amgen stock investors is that according to the Wave principle, this pattern should be followed by a three-wave decline, whose targets lie near the support area of wave (4). Wave (4) ended at $130.09 in late-September, 2015. With the stock currently at $182, we can expect another $50 to disappear from the share price. To reinforce the negative outlook, the MACD indicator shows a bearish divergence between waves (5) and (3). Now let’s take a closer look at Amgen stock’s post-earnings drop.
amgen stock hourly elliott wave analysis
Unfortunately, the hourly chart only tilts the table even more in the bears’ favor, by revealing the impulsive structure of the plunge to $168.45. Impulses point in the direction of the larger sequence, which in this case tell us that Amgen stock’s weakness is likely to continue. The weekly and hourly charts point in the same direction, so as long as the top of wave 5 of (5) at 201.22 holds, the bulls’ resistance remains futile.



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Tesla: Elliott Wave Aside, This is Totally Irrational

Tesla is up over 13% in pre-market trading today after news of its scheduled inclusion in the S&P 500 index on December 21st. The stock’s phenomenal rise since the COVID-19 crash led the company to a market cap of over $400 billion. This makes it much bigger than established rivals such as Volkswagen, Toyota and…

Read More »

Biogen, Elliott Wave and the Quest for Alzheimer Cure

Biogen is one of the top-notch firms in the biotech space. With sales of over $12.7B in 2019, the stock has been very generous to investors in the past. In fact, it is one of only five companies mentioned in Christopher W. Mayer’s book “100-Baggers” that have returned 100 to 1 in under six years.…

Read More »

Ryanair Stock, Unlike Its Planes, Can Fly Again Soon

Few industries have been hit harder by the COVID-19 pandemic restrictions than the airlines. Flight numbers and passenger traffic have been significantly reduced in Europe and the U.S. since March. Even low-cost carriers like Ryanair were not spared. Ryanair’s passenger traffic plunged by 99.5% in May and is still down 64% in September. Apparently nobody…

Read More »

General Mills Bearish Elliott Wave Cycle Spells Trouble

The last time we wrote about General Mills stock was over a year and a half ago. Following a bullish reversal Elliott Wave analysis helped us correctly predict in late-December 2018, the stock was trading above $51 a share in late-March 2019. It was a 33% recovery, whose structure, however, didn’t look quite as anticipated.…

Read More »

Fortinet Is Strong, but The Stock Can Slide 40% Anyway

Fortinet Inc. provides cybersecurity solutions to large and small businesses and enterprises. The company went public on the NASDAQ exchange in late-2009. Great timing, as it allowed it to enjoy the phenomenal post-crisis bull market. In fact, by July 2020, FTNT stock was up 794% since its IPO, easily beating the S&P 500’s return over…

Read More »

NIU Stock, Down 18% This Week, Can Fall Further

E-scooters have been all the rage in the past couple of years. Much friendlier to the environment and often more convenient as an urban transportation option than cars, electric scooters were quick to gain popularity. Niu Technologies, a Chinese manufacturer, has been bearing the fruits of this trend. The company’s ADS trade on the NASDAQ…

Read More »

Barry Callebaut Can Drop 25% as Fourth Wave Unfolds

Barry Callebaut AG is one of the largest cocoa processors and chocolate manufacturers in the world. Formed by the 1996 merger of Callebaut and Cacao Barry, the company produces over two million tonnes of cocoa and chocolate per year. Barry Callebaut went public on the SIX Swiss Exchange in 1998 and has been quite rewarding to investors ever since.…

Read More »

More analyses